Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127223872 | 12722387 | 2 | F | 201506 | 20160909 | 20160907 | 20160909 | EXP | BR-009507513-1609BRA002606 | MERCK | 70.00 | YR | F | Y | 72.00000 | KG | 20160909 | PH | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127223872 | 12722387 | 1 | PS | JANUMET XR | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | 1 TABLET, TWICE A DAY (BEFORE THE MAIN MEALS, LUNCH AND DINNER) | L025291 | 22044 | 1 | DF | PROLONGED-RELEASE TABLET | BID | |||||
| 127223872 | 12722387 | 2 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 1 TABLET, TWICE A DAY | 0 | 1 | DF | TABLET | BID | ||||||
| 127223872 | 12722387 | 3 | C | VASTAREL | TRIMETAZIDINE DIHYDROCHLORIDE | 1 | Oral | 1 TABLET, EVERY 12 HOURS | 0 | 35 | MG | TABLET | Q12H | ||||||
| 127223872 | 12722387 | 4 | C | SOMALGIN | ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE | 1 | Oral | TABLET A DAY | 0 | TABLET | QD | ||||||||
| 127223872 | 12722387 | 5 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 1 TABLET A DAY | 0 | 75 | MG | TABLET | QD | ||||||
| 127223872 | 12722387 | 6 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 1 TABLET A DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 127223872 | 12722387 | 7 | C | CEDUR | BEZAFIBRATE | 1 | Oral | 1 TABLET A DAY | 0 | 200 | MG | TABLET | QD | ||||||
| 127223872 | 12722387 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 1 TABLET A DAY | 0 | 40 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127223872 | 12722387 | 1 | Diabetes mellitus |
| 127223872 | 12722387 | 2 | Diabetes mellitus |
| 127223872 | 12722387 | 3 | Diabetes mellitus |
| 127223872 | 12722387 | 4 | Diabetes mellitus |
| 127223872 | 12722387 | 5 | Diabetes mellitus |
| 127223872 | 12722387 | 6 | Diabetes mellitus |
| 127223872 | 12722387 | 7 | Diabetes mellitus |
| 127223872 | 12722387 | 8 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127223872 | 12722387 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127223872 | 12722387 | Fall | |
| 127223872 | 12722387 | Hip fracture | |
| 127223872 | 12722387 | Product use issue | |
| 127223872 | 12722387 | Rheumatic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127223872 | 12722387 | 1 | 201506 | 0 | ||
| 127223872 | 12722387 | 2 | 2006 | 0 | ||
| 127223872 | 12722387 | 3 | 2006 | 0 | ||
| 127223872 | 12722387 | 4 | 2006 | 0 | ||
| 127223872 | 12722387 | 5 | 2006 | 0 | ||
| 127223872 | 12722387 | 6 | 2006 | 0 | ||
| 127223872 | 12722387 | 7 | 2006 | 0 | ||
| 127223872 | 12722387 | 8 | 2006 | 0 |